454 related articles for article (PubMed ID: 15368290)
21. Genetic and cellular basis of anti-DNA antibody synthesis in systemic lupus erythematosus of New Zealand mice.
Shirai T; Hirose S; Sekigawa I; Okada T; Sato H
J Rheumatol Suppl; 1987 Jun; 14 Suppl 13():11-20. PubMed ID: 3497267
[TBL] [Abstract][Full Text] [Related]
22. An Ig mu-heavy chain transgene inhibits systemic lupus erythematosus immunopathology in autoimmune (NZB x NZW)F1 mice.
Wellmann U; Letz M; Schneider A; Amann K; Winkler TH
Int Immunol; 2001 Dec; 13(12):1461-9. PubMed ID: 11717187
[TBL] [Abstract][Full Text] [Related]
23. Raloxifene modulates estrogen-mediated B cell autoreactivity in NZB/W F1 mice.
Zhang Y; Saha S; Rosenfeld G; Gonzalez J; Pepeljugoski KP; Peeva E
J Rheumatol; 2010 Aug; 37(8):1646-57. PubMed ID: 20551107
[TBL] [Abstract][Full Text] [Related]
24. Subset size, activation threshold and distribution of autoreactive MZ and FO B cells do not differ in a sex-specific manner in the NZB/W F1 murine lupus model: an experimental mouse study.
Enghard P; Grussie E; Rieder C; Burmester GR; Riemekasten G
Lupus; 2011 Oct; 20(12):1240-9. PubMed ID: 21844114
[TBL] [Abstract][Full Text] [Related]
25. Modulation of B-cell abnormalities in lupus-prone (NZB x NZW)F1 mice by normal bone marrow-derived B-lineage cells.
Shao DZ; Yamada S; Hirayama F; Hirano H; Ono S; Hamaoka T
Immunology; 1995 May; 85(1):16-25. PubMed ID: 7635516
[TBL] [Abstract][Full Text] [Related]
26. Major histocompatibility complex controls clonal proliferation of CD5+ B cells in H-2-congenic New Zealand mice: a model for B cell chronic lymphocytic leukemia and autoimmune disease.
Okada T; Takiura F; Tokushige K; Nozawa S; Kiyosawa T; Nakauchi H; Hirose S; Shirai T
Eur J Immunol; 1991 Nov; 21(11):2743-8. PubMed ID: 1718758
[TBL] [Abstract][Full Text] [Related]
27. Polyclonal B cell activation in lupus-prone mice precedes and predicts the development of autoimmune disease.
Klinman DM
J Clin Invest; 1990 Oct; 86(4):1249-54. PubMed ID: 2212009
[TBL] [Abstract][Full Text] [Related]
28. Identification and characterization of SmD183-119-reactive T cells that provide T cell help for pathogenic anti-double-stranded DNA antibodies.
Riemekasten G; Langnickel D; Ebling FM; Karpouzas G; Kalsi J; Herberth G; Tsao BP; Henklein P; Langer S; Burmester GR; Radbruch A; Hiepe F; Hahn BH
Arthritis Rheum; 2003 Feb; 48(2):475-85. PubMed ID: 12571858
[TBL] [Abstract][Full Text] [Related]
29. Differential control of CD22 ligand expression on B and T lymphocytes, and enhanced expression in murine systemic lupus.
Lajaunias F; Ida A; Kikuchi S; Fossati-Jimack L; Martinez-Soria E; Moll T; Law CL; Izui S
Arthritis Rheum; 2003 Jun; 48(6):1612-21. PubMed ID: 12794829
[TBL] [Abstract][Full Text] [Related]
30. Toxoplasma gondii infection inhibits the development of lupus-like syndrome in autoimmune (New Zealand Black x New Zealand White) F1 mice.
Chen M; Aosai F; Norose K; Mun HS; Ishikura H; Hirose S; Piao LX; Fang H; Yano A
Int Immunol; 2004 Jul; 16(7):937-46. PubMed ID: 15148287
[TBL] [Abstract][Full Text] [Related]
31. Expression and function of inducible costimulator on peripheral blood T cells in patients with systemic lupus erythematosus.
Yang JH; Zhang J; Cai Q; Zhao DB; Wang J; Guo PE; Liu L; Han XH; Shen Q
Rheumatology (Oxford); 2005 Oct; 44(10):1245-54. PubMed ID: 15987711
[TBL] [Abstract][Full Text] [Related]
32. Genetic susceptibility to polyI:C-induced IFNalpha/beta-dependent accelerated disease in lupus-prone mice.
Jørgensen TN; Thurman J; Izui S; Falta MT; Metzger TE; Flannery SA; Kappler J; Marrack P; Kotzin BL
Genes Immun; 2006 Oct; 7(7):555-67. PubMed ID: 16900204
[TBL] [Abstract][Full Text] [Related]
33. Failed self-tolerance and autoimmunity in IgG anti-DNA transgenic mice.
Tsao BP; Ohnishi K; Cheroutre H; Mitchell B; Teitell M; Mixter P; Kronenberg M; Hahn BH
J Immunol; 1992 Jul; 149(1):350-8. PubMed ID: 1607661
[TBL] [Abstract][Full Text] [Related]
34. Establishment of a nucleoside-specific suppressor T cell line from SLE prone (NZB/NZW)F1 mice.
Naiki M; Imai Y; Osawa T
J Immunol; 1985 Aug; 135(2):1080-5. PubMed ID: 2409137
[TBL] [Abstract][Full Text] [Related]
35. Analysis of the genetic encoding of oestradiol suppression of delayed-type hypersensitivity in (NZB x NZW) F1 mice.
Carlsten H; Holmdahl R; Tarkowski A
Immunology; 1991 Jun; 73(2):186-90. PubMed ID: 2071164
[TBL] [Abstract][Full Text] [Related]
36. Enforced Bcl-2 expression in B lymphocytes induces rheumatoid factor and anti-DNA production, but the Yaa mutation promotes only anti-DNA production.
Kuroki A; Moll T; López-Hoyos M; Fossati-Jimack L; Ibnou-Zekri N; Kikuchi S; Merino J; Merino R; Izui S
Eur J Immunol; 2004 Apr; 34(4):1077-84. PubMed ID: 15048718
[TBL] [Abstract][Full Text] [Related]
37. Regulation of immune function by calorie restriction and cyclophosphamide treatment in lupus-prone NZB/NZW F1 mice.
Sun D; Krishnan A; Su J; Lawrence R; Zaman K; Fernandes G
Cell Immunol; 2004 Mar; 228(1):54-65. PubMed ID: 15203320
[TBL] [Abstract][Full Text] [Related]
38. Cross-reactivity of IgG and IgM secreting B cells in normal and autoimmune mice.
Klinman DM
J Autoimmun; 1994 Feb; 7(1):1-11. PubMed ID: 8198696
[TBL] [Abstract][Full Text] [Related]
39. Development of autoimmune nephritis in genetically asplenic and splenectomized BAFF transgenic mice.
Fletcher CA; Groom JR; Woehl B; Leung H; Mackay C; Mackay F
J Autoimmun; 2011 Mar; 36(2):125-34. PubMed ID: 21216131
[TBL] [Abstract][Full Text] [Related]
40. Characterization of anti-single-stranded DNA B cells in a non-autoimmune background.
Nguyen KA; Mandik L; Bui A; Kavaler J; Norvell A; Monroe JG; Roark JH; Erikson J
J Immunol; 1997 Sep; 159(6):2633-44. PubMed ID: 9300682
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
